The oral diabetes drug used as an alternative to insulin injections has been found by a new study to be both safe and effective for pregnant women.
... risk of early puberty and insulin resistance, the diabetes drug metformin delayed the onset of menstruation ... studied whether a low dose of metformin, a drug that improves insulin resistance, would slow ...
WASHINGTON (AP) -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under recommendations made Wednesday by a government panel....
Diabetes drugs would be subject to more stringent safety standards under recommendations made Wednesday by a government panel.
WASHINGTON (AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be ...
The diabetes drug Byetta was linked to four more deaths in patients with pancreatitis, adding to two deaths announced by federal regulators last week.
... findings about a new advance in the study of major diabetes drug target. The advance - described by the researchers ... protein, PPAR gamma. PPAR gamma is a major drug target for the treatment of type 2 ...
... at the University of Leicester have published findings about a new advance in the study of major diabetes drug target. The advance - described by the researchers as 'very significant' - could lead to ...
... 10 percent of U.S. health-care expenditures.
The study acknowledges that indicators of benefit from diabetes drugs, such as average national levels of the hemoglobin A1c blood test, have improved ...
The diabetes drug Avandia should be banned over its risks of heart and liver damage, a U.S. consumer group urged.
... use of the family of diabetes drugs that includes rosiglitazone and pioglitazone doubles the risk of bone fractures in women, but not in men, according to a new analysis of several large clinical ...
WASHINGTON, Dec. 17 (UPI) -- The U.S. Food and Drug Administration is recommending companies developing type 2 diabetes drugs and biologics evaluate the products' cardiovascular risks.
The diabetes drug Actos needs a stronger warning on its label to highlight the risk of heart failure, Health Canada said Friday.
... University School of Medicine and the University of East Anglia show that long-term use of a popular class of oral diabetic drugs doubles the risk of fractures in women with type 2 ...
Treatment with the glitazone class of diabetes drugs leads to a "modest" increase in the risk of diabetic macular edema (DME)—a common complication that can lead to vision loss, reports a study in the ...
